Starling Oncology, Inc. (STLN) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−30.7x

Market Cap

$607.25M

MomentumView details →

1D Return

−0.20%

YTD Return

—

RSI (14)

48.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−30.7x

Market Cap

$607.25M

RSI (14)

48.2

MomentumView details →

1D Return

−0.20%

YTD Return

—

ProfitabilityView details →

Gross Margin

15.69%

Net Margin

−6.18%

EBITDA Margin

−3.72%

ROE (TTM)

145.67%

ROA (TTM)

−20.36%

Asset Turnover

3.39x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.08

EPS Surprise

−25.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.05

Avg Surprise (4Q)

−25.00%

Rev Surprise

3.56%

Capital & dividendView details →

Debt/Equity

−4.19x

Current Ratio

1.36x

Quick Ratio

1.15x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

587.24M

Net Income (TTM)

−36.29M

Op. CF (TTM)

328000.00

Latest newsMore news →

No recent news for STLN.

Similar companies

SoftMedx Healthcare Limited02951.HK Concord Healthcare Grp Co Ltd02453.HK Enhabit, Inc.EHAB The Oncology Institute, Inc.TOI Wenzhou Kangning Hospital Co., Ltd.02120.HK Wuhan Dazhong Dental Medical Co., Ltd.02651.HK Find similar companies →

Latest newsMore news →

No recent news for STLN.